Why Is Telomir Pharmaceuticals Stock Trading Higher On Tuesday?

On Tuesday, Telomir Pharmaceuticals, Inc. TELO revealed preclinical results confirming the efficacy of its licensed molecule Telomir-1 in reversing several key parameters of Type 2 diabetes mellitus.The study demonstrated significant reductions in fasting plasma glucose levels to basal levels, improved oral glucose homeostasis, and reversed insulin resistance to near pre-diabetic levels.These findings were supported by significantly improved Homeostatic Model Assessment of Insulin Resistance values, a stand ...